(RTTNews) – NanoString Technologies Inc. (NSTG) stated it respectfully disagreed with the decision of the jury in the U.S. District Court for the District of Delaware. The business will look for to have the decision reversed or changed in post-trial movements and after that anticipates to attract the U.S. Court of Appeals for the Federal Circuit, a court that focuses on patent conflicts.
On 17th November, the jury discovered that NanoString GeoMx Digital Spatial Profiler items infringe patents accredited to 10x Genomics and granting around $31 million in damages, including roughly $25 countless lost revenues and a $6 million royalty.
NanoString kept in mind that it stay undaunted in its belief that the patents that 10x Genomics has actually asserted explain an essentially various clinical approach than that which is utilized for GeoMx system. Basically, the business thinks the asserted patents are void, that it does not infringe these patents, which it ought to be vindicated on appeal.
NanoString likewise stated that it withdrew its complete year 2023 and 4th quarter monetary assistance, pending an evaluation of the effect of this lawsuits result on its service.
The views and viewpoints revealed herein are the views and viewpoints of the author and do not always show those of Nasdaq, Inc.
